Dissemin is shutting down on January 1st, 2025

Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 49(118), 2021

DOI: 10.1073/pnas.2106623118

Wiley Open Access, FASEB Journal, S1(36), 2022

DOI: 10.1096/fasebj.2022.36.s1.r4168

Links

Tools

Export citation

Search in Google Scholar

aPC/PAR1 confers endothelial anti‐apoptotic activity via a discrete β‐arrestin‐2 mediated SphK1‐S1PR1‐Akt signaling axis

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Significance Activated protein C (aPC) is a promising therapeutic and exhibits multiple pharmacological benefits in preclinical studies, including in sepsis. aPC activates protease-activated receptor-1 (PAR1) and signals via β-arrestin-2 to promote endothelial barrier stabilization and anti-inflammatory and anti-apoptotic activities. The present study demonstrates that different aPC/PAR1 cytoprotective responses are uniquely regulated by discrete β-arrestin-2–mediated signaling pathways that are modulated by coreceptors. Thus, β-arrestin-2 functions as a central driver of distinct, aPC/PAR1-induced cytoprotective signaling pathways to control barrier protection and anti-apoptotic activities.